心脉医疗（688016）披露拟取消监事会并修订多项制度，11月04日股价下跌2.85%

Core Viewpoint - The company Xinmai Medical (688016) is set to hold its first extraordinary general meeting of shareholders on November 14, 2025, to discuss significant proposals, including the cancellation of the supervisory board and the transfer of its powers to the audit committee of the board of directors [1] Group 1: Stock Performance - As of the close on November 4, 2025, Xinmai Medical's stock price was 99.34 yuan, down 2.85% from the previous trading day [1] - The stock opened at 101.98 yuan, reached a high of 102.2 yuan, and a low of 99.03 yuan, with a trading volume of 1.66 billion yuan and a turnover rate of 1.34% [1] Group 2: Shareholder Meeting Proposals - The extraordinary general meeting will review multiple important proposals, with the most notable being the proposed cancellation of the supervisory board, transferring its powers to the audit committee of the board [1] - The company plans to amend eight internal regulations, including the rules for shareholder meetings and board meetings, in accordance with the new Company Law and relevant regulatory requirements [1] - To enhance risk management, the company intends to purchase liability insurance for directors and senior management with a coverage amount of 50 million yuan per year, and an annual premium not exceeding 300,000 yuan [1]